These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28698146)

  • 1. Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
    Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1407-1413. PubMed ID: 28698146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
    Terashima M; Tange S; Ishimura A; Suzuki T
    J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.
    Enkhbaatar Z; Terashima M; Oktyabri D; Tange S; Ishimura A; Yano S; Suzuki T
    Cell Cycle; 2013 Jul; 12(13):2100-12. PubMed ID: 23759590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
    Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
    PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
    Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
    Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
    J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer.
    Ma J; Zhang J; Weng YC; Wang JC
    Mol Cells; 2018 Sep; 41(9):868-880. PubMed ID: 30304920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
    Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
    Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
    Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
    Lee SW; Park DY; Kim MY; Kang C
    Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells.
    Zhang Z; Lei A; Xu L; Chen L; Chen Y; Zhang X; Gao Y; Yang X; Zhang M; Cao Y
    J Biol Chem; 2017 Aug; 292(31):12842-12859. PubMed ID: 28634230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chidamide alleviates TGF-β-induced epithelial-mesenchymal transition in lung cancer cell lines.
    Lin SH; Wang BY; Lin CH; Chien PJ; Wu YF; Ko JL; Chen JJ
    Mol Biol Rep; 2016 Jul; 43(7):687-95. PubMed ID: 27188428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.
    Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
    Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
    Leng X; Wang J; An N; Wang X; Sun Y; Chen Z
    Oncogene; 2020 Oct; 39(41):6468-6479. PubMed ID: 32879445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
    Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
    Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.